Pittenger & Anderson’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Pittenger & Anderson's UTHR Position: Q3 2026 in Review
Pittenger & Anderson sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 3 shares — an estimated $1.63K sold.
Pittenger & Anderson first reported a position in UTHR in Q1 2022 and held it in 4 quarters. The position peaked at $1.63K in Q2 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Pittenger & Anderson reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
- Pittenger & Anderson sold 3 United Therapeutics shares in Q3 2026, an estimated $1.63K.
- Pittenger & Anderson first reported a position in United Therapeutics in Q1 2022 and held it in 4 quarters.
- Pittenger & Anderson's United Therapeutics position peaked at $1.63K in Q2 2026.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.